Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • Coinfection with HIV
  • HBV testing and linkage to care
  • HCV testing and linkage to Care
  • Linkage to care
  • Persons who inject drugs: Medication assisted therapy
  • Screening and diagnosis
  • Testing
  • Treatment
  • Adolescents (10 - 19 years of age)
  • Adults
  • Birth cohorts of adults
  • Blood transfusion recipients
  • Dialysis patients
  • General Population
  • Immigrants/Refugees
  • Incarcerated populations (current and former)
  • Men who have sex with men
  • Persons who inject drugs
  • Persons with substance use disorder
  • Young Adults <21
  • (-) Cross-sectional
  • Australia
  • Brazil
  • Cambodia
  • Cameroon
  • Chad
  • Egypt
  • Iran (Islamic Republic of)
  • Ireland
  • Italy
  • Japan
  • Kenya
  • Malaysia
  • Netherlands
  • Pakistan
  • Poland
  • Portugal
  • Russian Federation
  • Serbia
  • Spain
  • Sri Lanka
  • Switzerland
  • Taiwan
  • Ukraine
  • United Kingdom
  • United States of America
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based HCV core antigen (cAg) confirmatory test
  • Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care PCR/RNA test
Displaying 1 - 12 of 56
  • Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities

    2014
    BMC Infectious Diseases

    14 (supplement)

  • Hepatitis B, hepatitis C, and human immune deficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance hemodialysis in cameroon

    2016
    Iranian Journal of Kidney Diseases

    10

    304-309
  • Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department

    2015
    Hepatology

    61

    776-782
  • Public health clinic-based hepatitis C testing and linkage to care in Baltimore

    2016
    Journal of Viral Hepatitis

    23

    366-374
  • Health status of Afro-Asian refugees in an Italian urban area: a cross-sectional monocentric study

    2018
    Public Health

    158

    176-182
  • Using HIV Surveillance Data for Targeted, Community-based Hepatitis C Virus Testing among Baby Boomers in Washington, D.C

    2018
    Journal of health care for the poor and underserved

    29

    964-974
  • The seroprevalence of untreated chronic hepatitis c virus (HCV) infection and associated risk factors in male irish prisoners: A cross-sectional study, 2017

    Eurosurveillance

    24

  • Prevalence and correlates of HIV and hepatitis c virus infections and risk behaviors among Malaysian fishermen

    2015
    PLoS ONE

    10

  • The characteristics of residents with unawareness of hepatitis C virus infection in community

    2018
    PLoS ONE

    13

  • Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil

    2020
    BMC Infectious Diseases

    20

  • A population-based screening for hepatitis C antibodies and active infection using a point-of-care test in a low prevalence area

    2020
    PLoS ONE

    15

  • Use and acceptability of salivary hepatitis C virus testing in an English Young Offender Institution

    2017
    International Journal of STD & AIDS

    28

    1234-1238

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page ››
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q